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Abstract
Background
More than 260 million people live with schistosomiasis and regular mass-treatment should
be implemented to prevent morbidity. Praziquantel, dosed at 40 milligrams per kilogram
bodyweight, is the drug of choice. During the last decades the WHO Tablet Pole–which esti-
mates tablet need by height as representing weight–has been used as a practical and
cheap tool in mass treatment. In South Africa this method could be inaccurate given the
prevalence of overweight and obesity. In this study in female pupils in KwaZulu-Natal,
South Africa, we explored the accuracy of the WHO Tablet Pole and the recently developed
Modified Dose Pole for adults with two additional intervals and correction for body mass
index (BMI).
Methodology
In randomly selected primary and secondary schools of schistosomiasis-endemic areas,
height and weight of female pupils were measured. TheWHO Tablet Pole and Modified
Dose Pole were used to indicate the amount of praziquantel according to height and the
dose in milligrams per kilogram bodyweight was calculated. The BMI correction was per-
formed by adding 600 milligrams (1 tablet) to the indicated dose if a person was overweight/
obese.
Principal Findings
3157 female students were investigated and 35% were found to be overweight/obese.
Using the WHO Tablet Pole, 73% would have received an adequate dose (range 30–60
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mg/kg). When correcting for BMI, this would have been 94%. Using the Modified Dose Pole
with BMI correction, 97% would have been adequately treated.
Conclusions
This study shows that the WHO Tablet Pole will be inaccurate in estimating the dose of pra-
ziquantel in South African girls due to high prevalence of overweight/obesity. Under-dosing
of individuals who appear overweight/obese could be largely prevented by adding an extra
praziquantel tablet to the recommended dose. Further research must be done to explore if
subjective weight estimates are reliable.
Author Summary
Schistosomiasis is an acute and chronic parasitic disease caused by Schistosoma worms,
contributing to morbidity and mortality in 261 million people, mainly in poor, rural com-
munities. In an effort to control schistosomiasis, the World Health Organization advocates
for regular mass treatment to at-risk populations, administering free praziquantel (40mg/
kg). The WHO Tablet Pole, which estimates the number of tablets for each individual by
height, is recommended for the dosing of praziquantel. A Modified Dose Pole with two
additional height intervals has been developed for adults. In addition, the developers of the
Modified Dose Pole suggest to add an extra tablet to the indicated dose if the person
appears to be overweight/obese (“correction for body mass index (BMI)”). This study
explored the accuracy of these dose pole programmes in 3157 school-girls in schistosomia-
sis-endemic KwaZulu-Natal, South Africa. Overweight or obesity was found in 35% of the
study population. With the WHO Tablet Pole, only 73% would have received an accept-
able dose (30-60mg/kg), whereas when correcting for overweight/obesity almost all the
girls would have been adequately treated. We suggest adding one tablet to the dose recom-
mended by the WHO Tablet Pole if a person appears to be overweight/obese to prevent
under-dosing of these individuals.
Introduction
Schistosomiasis remains an important health challenge in poor, rural communities, contribut-
ing to significant morbidity and mortality [1,2]. As a means to control schistosomiasis, the
World Health Organization (WHO) advocates for regular treatment with praziquantel (PZQ)
of at-risk populations, an intervention that has been shown to be safe and cost-effective [3,4].
South Africa, particularly in the Eastern and Northern parts of the country, is endemic for
schistosomiasis and an estimated 2.4 million school-aged children and 2.7 million adults
require treatment with praziquantel yearly or every second year [3,5].
Though often times neglected, schistosomiasis has recently gained attention as several stud-
ies suggest that it may increase the risk of HIV infection in females [6–10]. The prevalence of
HIV/AIDS in South Africa is among the highest in the world [11] and it has been proposed
that regular mass-treatment of schistosomiasis could both reduce the burden of disease and
have an impact on HIV transmission rates [12,13].
Currently, South Africa has no national schistosomiasis control programme. However, the
South African Integrated School Health Policy (ISHP) has adopted a policy to offer regular treat-
ment to children attending schools in schistosomiasis-endemic areas [5,14]. Between the years
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1997 and 2000 a helminth-control programme (including schistosomiasis treatment) was piloted
in KwaZulu-Natal, revealing the necessity and efficacy of regular treatment of schistosomiasis [15].
Treating schistosomiasis requires a praziquantel dose that is adjusted to bodyweight; 40 milli-
grams per kilogram (mg/kg) [16]. The provision and maintenance of weight scales to the
endemic schools that are mostly remote and located in rural areas may constitute a major imped-
iment for implementation of school-based programmes. Hall et al. therefore investigated an alter-
native for bodyweight and found that in children from Tanzania, Ghana andMalawi, height
roughly corresponded to bodyweight [17]. In 2001, theWHO Tablet Pole–which estimates the
dose of praziquantel by height–was developed and this pole has been recommended for mass-
treatment of school-aged children [18,19]. A revision of this dose pole which allows for inclusion
of preschool-aged children was proposed by Sousa-Figueiredo et al.[20]. Though theWHO Tab-
let Pole has been validated in multiple populations, recent studies have discussed its reduced
accuracy in groups where height and bodyweight are less correlative [21–23]. Palha De Sousa
et al. have shown that in adults, overweight or obese individuals are likely to receive an insuffi-
cient dose when using theWHO Tablet Pole [23]. Therefore, a Modified Dose Pole–which incor-
porates a correction for body mass index (BMI)–was developed for use in adults [23].
South Africa has the highest prevalence of childhood obesity of sub-Saharan Africa; 19% of
boys and 26% of girls below the age of 20 years are estimated to be overweight or obese [24].
Yet the accuracy of the WHO Tablet Pole in this population remains undetermined. In light of
the pending treatment programmes in South Africa, this study sought to explore the accuracy
of dosing by height and the necessity to correct for overweight/obesity in girls of primary and
secondary schools in KwaZulu-Natal.
Methods
Study design and participants
This cross-sectional study made use of two data sets originating from on-going studies on
schistosomiasis in girls and young women in KwaZulu-Natal. The first data set was collected in
18 randomly selected primary schools (2009–2010) and included girls between 10 and 12 years
of age. The second data set was collected in 70 randomly selected secondary schools (2011–
2013) and included adolescent girls, aged 16 years and above. Selection of the schools was con-
ducted through systematic sampling from all large and medium size schools in the districts and
all girls within the target population were invited to participate in the study.
For both cohorts, exclusion criteria were absence on the invitation days, serious illness or lack
of consent. For the present study, all individuals from the original study population (n = 3419)
who were lacking data on height, weight or age were excluded (n = 206). Furthermore, of the sec-
ondary school cohort, all pupils above the age of 23 years were excluded (n = 56).
Participants originated from the coastal districts of KwaZulu-Natal; Ugu, Ilembe, and
Uthungulu, which are all endemic for S. haematobium [5]. KwaZulu-Natal is one of the nine
provinces of South Africa and has approximately 10.3 million inhabitants, of which more than
half reside in rural areas [25]. An average of 56.6% of the households in KwaZulu-Natal live
below national poverty lines and 14.1% have no access to piped water [26,27]. Furthermore,
even if they have access to potable water, many continue to use the river and dams for recrea-
tional purposes, laundry and bathing.
Ethical considerations
This study drew from a larger project that was approved by the Biomedical Research Ethics Admin-
istration, University of KwaZulu-Natal (BREC, 2009, Ref BF029/07), the Departments of Health
and Education of KwaZulu Natal (2009, Ref HRKM010-08), The Norwegian Ethics Committee,
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Eastern Norway (REC, 2007, Ref IRB 0000 1870, amended 2011), The European Group on Ethics
in Science and New Technologies (2011, Ref IRSES-2010:269245), and the Departments of Health
(2008) and Education in Ugu (2009), Ilembe (2012) and Uthungulu (2013).
Information sessions were held at each school before invitation to participate in the study.
All participants signed individual informed consent forms. Assenting participants younger
than 12 years of age were only included if a consent form was signed by their guardian. The
ethical committees, BREC (annual renewal) and REC, specifically approved the consent proce-
dures for adolescents below the age of 18 years (independent minor consent, no parental con-
sent) [9]. School-based treatment was offered to all students in the included schools by the
Districts’ Departments of Health.
Data collection
One to three urine samples were collected and analysed for the presence of Schistosoma eggs as
a part of the nested cohort study. For comparability reasons, only the first urine sample was
taken into account in the present study. An individual was considered to be schistosomiasis
positive if at least one terminal spined ovum was seen in the urine sample.
Height was measured up to a precision of 1 cm, using a stadiometer. Weight was measured
up to a precision of 0.1 kg, using an electronic scale. Each individual was classified as under-
weight, normal weight, overweight or obese, based on the calculated body mass index (BMI,
height/weight2). In adults (18 years of age and above) underweight, normal weight, overweight,
and obese were defined as a BMI less than 18.5, from 18.5 to 25, from 25 to 30, and more than
30, respectively. In individuals under the age of 18 years, the BMI classification was based on
the International Obesity Task Force cut-off points (IOTF) (S1 Table) [24,28].
Data analysis
TheWHO Tablet Pole and the Modified Dose Pole are presented in Fig 1. The accuracy of the
dose pole programmes in indicating a dose of 40mg/kg was investigated by calculating the dose
in mg/kg that would have been assigned to each individual in the study population. Based on
their height, individuals were classified in one interval of each dose pole. The indicated dose in
milligrams (mg) was then divided by the bodyweight of the individual. The correction for BMI
was performed by adding one 600 mg tablet to the total dose if an individual was classified as
overweight or obese.
The optimal dose was defined as receiving 40 to 60 mg praziquantel per kilogram body-
weight; receiving less than 30 mg/kg was defined as an insufficient dose and an excessive dose
was defined as receiving more than 60 mg/kg. A dose between 30 and 60 mg praziquantel per
kilogram was considered to be an appropriate dose [16,18,29].
Statistical analyses were performed using IBM SPSS statistics version 22. Chi-square was
used to compare the prevalence of overweight and obesity and schistosomiasis between the pri-
mary and secondary school cohort. Multivariate Odds Ratio (OR) was used to investigate an
association between receiving an insufficient dose and being overweight or obese. For the per-
centages of the population within each dosing category or BMI classification, 95% Confidence
Intervals (CI) were given.
Results
Group characteristics
The study population included 3157 female students of which 1008 were in primary schools
and 2149 in secondary schools. The median age of the primary school students was 11 years
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(range 10–12); in the secondary school students the median age was 18 years (range 16–23) (S1
Dataset). In the students for whom a urine sample was investigated (n = 2968), the prevalence
of S. haematobium infection was on average 22.6% (CI 21.1–24.1). The prevalence of infection
was significantly higher in primary schools (32.2%, 302/938, CI 29.3–35.3), as compared to sec-
ondary schools (18.2%, 369/2030, CI 16.5–19.8, p<0.01).
BMI distribution
Overweight or obesity was found in 34.5% (CI 32.9–36.2) of the study population. It was more
common in secondary school students (40.9%, CI 38.5–43.0) than in primary school students
(21.0%, CI 18.6–23.5). The prevalence of underweight was 4.5% (CI 3.8–5.2). The prevalence
of obesity was 6.3% (CI 3.6–9.2) in the youngest age group (10 years of age) and 14.5% (CI 5.5–
23.6) in the oldest age group (23 years of age). This difference was not significant, however the
Fig 1. TheWHO Tablet Pole (A) and the Modified Dose Pole (B). TheWHO Tablet Pole (A) and the
Modified Dose Pole (B) have 7 and 9 height intervals respectively that indicate the corresponding dose of
praziquantel in tablets of 600 mg each. BMI correction can be performed by adding one tablet of praziquantel
for overweight and obese patients. The use of pictograms has been proposed to simplify BMI classification in
practice [23].
doi:10.1371/journal.pntd.0004623.g001
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prevalence of overweight was significantly higher in those 23 years of age (41.8%, CI 23.3–54.5)
compared to those 10 years of age (15.5%, CI 11.5–20.1, p<0.01). Schistosomiasis infection
was found in 32.0% (CI 25.9–38.1) of the overweight/obese students in primary schools and in
15.6% (CI 13.1–18.2) of the overweight/obese students in secondary schools. The prevalence of
S. haematobium was not significantly different in overweight/obese individuals compared to
those with a normal BMI, when corrected for age.
Dosing based on height
In our study population we found a large variation of bodyweight, which can only partly be
explained by the variation in height (r2 = 0.55). For the height intervals in the WHO Tablet
Pole, a large weight range was observed for each interval, as shown in Fig 2. The same dose
would have been indicated to persons whose bodyweights varied on average 60 kg per dose
interval. The weight range was largest (31–117 kg) in the 160–178 cm height interval (corre-
sponding with 4 tablets).
The dosages that would have been provided using the WHO Tablet Pole and the Modified
Dose Pole are presented in Table 1. Of the study population 73.0% (CI 71.3–74.4) would have
Fig 2. The weight range for theWHO Tablet Pole height intervals. All individuals in one interval would have received the same number of praziquantel
tablets.
doi:10.1371/journal.pntd.0004623.g002
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received an appropriate dose (30 to 60 mg/kg) with theWHO Tablet Pole. In the primary
schools, 89.2% (CI 87.3–91.0) would have been given a dose between 30 and 60 mg/kg compared
to 65.3% (CI 63.2–67.3) in the secondary schools. Using the BMI correctedWHO Tablet Pole
93.6% (CI 92.7–94.5) of the total population would have received an appropriate dose of prazi-
quantel. In the primary schools this was 98.6% (CI 97.8–99.3), whereas in secondary schools
91.2% (CI 90.0–92.4) would have received enough praziquantel (S2 Dataset). Almost 96.5% (CI
95.8–97.1) of the total population would have received an appropriate dose if using the BMI cor-
rected Modified Dose Pole (p<0.001). If not correcting for BMI, the Modified Dose Pole would
have resulted in 79.9% (CI 78.5–81.3) receiving an appropriate dose, a significant difference com-
pared to theWHO Tablet Pole (p<0.001). The percentage that would have received an excessive
dose (more than 60 mg/kg) was 0.1% for all dose pole programmes. Of the total population,
27.0% (CI 25.5–28.6) would have received an insufficient dose (less than 30 mg/kg) using the
WHO Tablet Pole, but only 0.9% would have received doses below 20 mg/kg (data now shown).
The average dose that would have been given using theWHO Tablet Pole was 34.7 mg/kg, which
falls into the lower end of the appropriate range. Using the BMI correctedWHO Tablet Pole the
average dose would have been 37.9 mg/kg. The average dose that would have been indicated by
the Modified Dose Pole with BMI correction was 39.4 mg/kg.
The relationship between the body mass index and the dose that would have been indicated
using the WHO Tablet Pole is shown in Fig 3. Being overweight or obese was associated with
receiving an insufficient dose (OR 38.5, CI 30.5–48.5). Of all cases that would have received an
insufficient dose, 55.9% were overweight and 31.3% were obese. Of the individuals that were
classified as obese, 97.1% would have received an insufficient dose using the WHO Tablet Pole.
The maximum dosage using the WHO Tablet Pole is 3000 mg of praziquantel (for the height
interval 178–190 cm), but this dose would only be sufficient for bodyweights up to 75 kg
(assuming a praziquantel dose of 40 mg/kg). Of the study population, 109 individuals (3.5%)
weighed more and would have required more praziquantel.
Simulating a dose pole designed for praziquantel dosing at 60 mg/kg rather than the stan-
dard 40mg/kg (by adding 50% in each of the height intervals), 77.2% (CI 75.8–78.7) of the pop-
ulation would have received a dose between 30 and 60 mg/kg, while 21.9% (CI 20.4–23.2)
would have received more than 60 mg/kg. Out of the 3157 pupils, 10 (0.3%) would have been
given more than 80 mg/kg. Only 0.9% would have received a dose of less than 30 mg/kg.
Table 1. Dosages of praziquantel that would have been administered using theWHO Tablet Pole and the Modified Dose Pole (with and without BMI
correction) in a population of 3157 female students of primary and secondary schools in South Africa.
Dosing category WHO Tablet Pole Modiﬁed Dose Pole
Without BMI correction With BMI
correction
Without BMI
correction
With BMI
correction
10–12 years a
(n = 1008)
16–23 years b
(n = 2149)
Total
(n = 3157)
Total (n = 3157) Total (n = 3175) Total (n = 3175)
Insufﬁcient (<30 mg/kg) 10.7% 34.6% 27.0% 6.3% 20.0% 3.4%
Acceptable (30–40 mg/
kg)
50.6% 51.4% 51.2% 61.4% 50.8% 53.1%
Optimal (40–60 mg/kg) 38.6% 13.9% 21.8% 32.2% 29.1% 43.4%
Excessive (60 mg/kg) 0.1% 0.1% 0.1% 0.1% 0.1% 0.1%
The acceptable and optimal dosages are deﬁned as appropriate.
aPrimary school
bSecondary school
doi:10.1371/journal.pntd.0004623.t001
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Total use of tablets
Using the WHO Tablet Pole, 9543 tablets would have been required for a population of 3157
girls; on average 3 tablets per girl. If a correction for BMI was used for the WHO Tablet Pole,
10633 tablets would be needed, which is 11% more than without this correction. The Modified
Dose Pole with BMI correction required 17% more tablets (S2 Dataset). Per 1000 pupils in pri-
mary schools 210 extra tablets would be needed and per 1000 pupils in secondary schools 409
extra tablets would be needed when correcting for BMI using the WHO Tablet Pole.
Dosing based on bodyweight
Dosing based on bodyweight requires the availability of weight scales. Relatively robust elec-
tronic bathroom scales that can weigh one thousand children repeatedly cost USD 15–20 per
scale, whereas the dose pole can be printed on paper and be hung on the wall. If one scale is
bought per 300 pupils they would cost USD 165 000 as a conservative estimate (Table 2).
Fig 3. The relationship between bodymass index and dose received using theWHO Tablet Pole. The increase in tablet interval (from½ tablet to 1) at a
height of 160 cm appears as a gap in the study population. The horizontal lines present the range of an appropriate praziquantel dose between 30–60 mg/kg.
doi:10.1371/journal.pntd.0004623.g003
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Mass-treatment is performed yearly or every second year and the scales would either have to be
stored centrally or at each school. If stored centrally only 665 scales would be needed for the
same number of schools, but 40 metres of shelves would be needed to store them (45 cm high,
6 cm width per scale × 665 scales). In addition, there would be a cost for distribution in a timely
manner to each school. Furthermore, batteries would have to be ensured.
Discussion
In girls of primary and secondary schools in rural KwaZulu-Natal, South Africa, we found a
prevalence of schistosomiasis of 23%, showing the necessity of finding an accurate dose pro-
gramme to be used in regular mass treatment. This study indicates a low accuracy of the WHO
Tablet Pole as one in four girls would have received an insufficient dose of praziquantel (less
than 30 mg/kg). Of the study population 35% were overweight or obese and this group was at
particular risk of receiving an insufficient dose of praziquantel. Looking at primary school girls
separately, a better performance of the WHO Tablet Pole was found; 89% would have received
a dose above 30 mg/kg. The Modified Dose Pole would have indicated a right dose in 97% of
all girls and was significantly more accurate than the WHO Tablet Pole, due to its ‘BMI correc-
tion’. When adding this correction to the WHO Tablet Pole, 94% of all girls would have
received an appropriate dose.
Several previous studies have found that the WHO Tablet Pole is accurate, indicating a cor-
rect dose in more than 95% of the population [18,29,30]. The WHO Tablet Pole has therefore
rightfully been recommended and used in mass-treatment of children, when no weight scales
are available. However, since the previously mentioned studies were carried out, the global
prevalence of overweight and obesity has continued to increase, affecting some countries more
than others [24]. We found that overweight and obesity were very common in our study popu-
lation, explaining the poor accuracy of the WHO Tablet Pole. The high prevalence of over-
weight and obesity in South Africa compared to neighbouring countries, has been indicated by
the Global Burden of Disease Study [24]. Several studies investigating the accuracy of the
WHO Tablet Pole in adult populations, have pointed out the issue of under-dosing of adults as
height correlates poorly with bodyweight [22,23]. Our study shows the same in a young popu-
lation. Yet under-dosing appears to pose a bigger problem among older children and adoles-
cents than among younger primary school children.
We are aware that this research has limitations. Firstly, we did not investigate the accuracy
of the WHO Tablet Pole in South African boys. The larger project from which our data was
derived focuses on female genital schistosomiasis (FGS) as a risk factor for reproductive tract
morbidity and HIV and did therefore not collect data on boys. We cautiously suggest that the
management of schistosomiasis in girls might be more urgent as female genital schistosomiasis
Table 2. The cost of weight scales for mass treatment in schools in the KwaZulu-Natal Province.
School size Scales per school Number of schools this sizea Number of scales neededb Price per scale (USD) Price total (USD)
Up to 300 pupils 1 1 909 1 909 15
300–600 pupils 2 1 946 3 892 15
600–900 pupils 3 957 2 871 15
More than 900 pupils 3 795 2 385 15
Totals 5 607 11 057 15 165 855
aIn KwaZulu-Natal Province.
bIf scales are left in the schools.
doi:10.1371/journal.pntd.0004623.t002
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is suggested to cause an increased risk of HIV infection. However the findings on dosing prazi-
quantel in overweight/obese individuals will likely also apply to boys as 19% of South African
boys below the age of 20 years have been estimated to be either overweight or obese [24].
Hence the WHO Tablet Pole would indicate insufficient praziquantel dosages in boys as well.
This study solely focused on the delivery of the recommended praziquantel dose by different
dose pole programmes. Further research is required to show if a dose pole programme which
allows administration of low doses is less efficient in reducing the schistosomiasis prevalence
on a population level. There is still some controversy surrounding the dose at which praziquan-
tel should be administered, since effects of the drug have been reported at low doses of 20 mg/
kg [16,31,32] However, low doses of praziquantel result in lower cure rates, which would limit
the effect of treatment programmes on the overall morbidity and prevalence of schistosomiasis
[16,32,33]. With regards to under-dosing overweight and obese individuals it should also be
considered that the biological availability of the drug might be lower as a result of the drug dis-
tribution in body fat. We believe that, as long as no more data is available, treatment pro-
grammes should aim to deliver at least the recommended dose of 40 mg/kg [16,19].
Dosing by bodyweight remains the most accurate method to deliver the recommended dose
of praziquantel. However, using weight scales would entail a substantial cost and logistical hur-
dle for implementing mass treatment programmes. When compared to dosing with a height
pole, weighing each individual is more complicated and time consuming. In addition, weight
scales are valuable, and safe storage and maintenance must be ensured either within each
school or at each central point. In practice, the reliability of scales may be limited by incorrect
use, defects in the calibration, or by lack of batteries. Dosing by height with a dose pole would
represent a major alleviation of these inconveniences. Our study shows that the accuracy of the
commonly used WHO Tablet Pole will be improved with a correction for overweight/obesity.
In our study, this correction was based on the calculated BMI as the height and weight of each
individual were measured. In practice this correction would be based on the dispenser’s estima-
tion of the individual’s BMI since weight scales are not available. Based on a person’s physical
appearance, one extra tablet of praziquantel could be administered to those who appear to be
overweight/obese.
Dosing medication based on a person’s physical appearance was investigated by Alexander
et al. for the dosing of invermectin [34]. An assistant was instructed to place people in one of
four dosing categories based on their physical appearance. Alexander et al. showed that in 80%
of the cases the estimation of the category was correct, with a maximum of one category off-tar-
get [34]. Taking that into account, it will likely be possible for fieldworkers to estimate if a per-
son is overweight/obese and thus in need of an additional tablet. However, this method has not
yet been validated for this specific context and would need further investigation for its accu-
racy. To achieve a more precise estimation of a person’s BMI, the use of pictograms has been
suggested and this method was explored in a Danish population by Stunkard et al. [35]. The
pictograms that were developed were later assessed in an Iranian population and were shown
to be valid for discriminating between normal, overweight and obese people [36]. To our
knowledge the use of pictograms to estimate BMI has not yet been validated in a South African
population and therefore further research into this topic is needed before implementation of
such a tool.
The WHO Tablet Pole remains an important tool in current dosing practices and is rather
accurate in young children. However, to increase its accuracy for older age groups, incorpo-
ration of the additional height intervals of the Modified Dose Pole should be considered in
future revision of the WHO Tablet Pole.
Our study suggests that in South Africa and other countries heavily affected by the obesity
epidemic, the accuracy of anti-schistosomal treatment could be improved by using the WHO
Dose Poles and Obesity in Schistosomiasis Control
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Tablet Pole with a correction for BMI by instructing fieldworkers to administer one extra tablet
of praziquantel to those who appear overweight or obese.
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